Cargando…

Intestinal Dominance by Multidrug-Resistant Bacteria in Pediatric Liver Transplant Patients

Pediatric liver transplantation (PLTx) is commonly associated with extensive antibiotic treatments that can produce gut microbiome alterations and open the way to dominance by multidrug-resistant organisms (MDROs). In this study, the relationship between intestinal Relative Loads (RLs) of β-lactamas...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahdouh, Elias, Fernández-Tomé, Lorena, Cendejas-Bueno, Emilio, Ruiz-Carrascoso, Guillermo, Schüffelmann, Cristina, Alós-Díez, María, Lázaro-Perona, Fernando, Castro-Martínez, Mercedes, Escosa-García, Luis, Jiménez-Rodríguez, Sonia, Hierro-Llanillo, Loreto, Mingorance, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769714/
https://www.ncbi.nlm.nih.gov/pubmed/36346231
http://dx.doi.org/10.1128/spectrum.02842-22
_version_ 1784854431388401664
author Dahdouh, Elias
Fernández-Tomé, Lorena
Cendejas-Bueno, Emilio
Ruiz-Carrascoso, Guillermo
Schüffelmann, Cristina
Alós-Díez, María
Lázaro-Perona, Fernando
Castro-Martínez, Mercedes
Escosa-García, Luis
Jiménez-Rodríguez, Sonia
Hierro-Llanillo, Loreto
Mingorance, Jesús
author_facet Dahdouh, Elias
Fernández-Tomé, Lorena
Cendejas-Bueno, Emilio
Ruiz-Carrascoso, Guillermo
Schüffelmann, Cristina
Alós-Díez, María
Lázaro-Perona, Fernando
Castro-Martínez, Mercedes
Escosa-García, Luis
Jiménez-Rodríguez, Sonia
Hierro-Llanillo, Loreto
Mingorance, Jesús
author_sort Dahdouh, Elias
collection PubMed
description Pediatric liver transplantation (PLTx) is commonly associated with extensive antibiotic treatments that can produce gut microbiome alterations and open the way to dominance by multidrug-resistant organisms (MDROs). In this study, the relationship between intestinal Relative Loads (RLs) of β-lactamase genes, antibiotic consumption, microbiome disruption, and the extraintestinal dissemination of MDROs among PLTx patients is investigated. 28 PLTx patients were included, from whom 169 rectal swabs were collected. Total DNA was extracted and bla(CTX-M-1-Family), bla(OXA-1), bla(OXA-48), and bla(VIM) were quantified via quantitative polymerase chain reaction (qPCR) and normalized to the total bacterial load (16SrRNA) through LogΔΔCt to determine the RLs. 16SrRNA sequencing was performed for 18 samples, and metagenomic sequencing was performed for 2. Patients’ clinical data were retrieved from the hospital’s database. At least one of the genes tested were detected in all of the patients. The RLs for bla(CTX-M-1-Family), bla(OXA-1), bla(OXA-48), and bla(VIM) were higher than 1% of the total bacterial population in 67 (80.73%), 56 (78.87%), 57 (77.03%) and 39 (61.9%) samples, respectively. High RLs for bla(CTX-M-1-Family), bla(OXA-1), and/or bla(OXA-48), were positively associated with the consumption of carbapenems with trimethoprim-sulfamethoxazole and coincided with low diversity in the gut microbiome. Low RLs were associated with the consumption of noncarbapenem β-lactams with aminoglycosides (P < 0.05). Extraintestinal isolates harboring the same gene(s) as those detected intraintestinally were found in 18 samples, and the RLs of the respective swabs were high. We demonstrated a relationship between the consumption of carbapenems with trimethoprim-sulfamethoxazole, intestinal dominance by MDROs and extraintestinal spread of these organisms among PLTx patients. IMPORTANCE In this study, we track the relative intestinal loads of antibiotic resistance genes among pediatric liver transplant patients and determine the relationship between this load, antibiotic consumption, and infections caused by antibiotic-resistant organisms. We demonstrate that the consumption of broad spectrum antibiotics increase this load and decrease the gut microbial diversity among these patients. Moreover, the high loads of resistance genes were related to the extraintestinal spread of multidrug-resistant organisms. Together, our data show that the tracking of the relative intestinal loads of antibiotic resistance genes can be used as a biomarker that has the potential to stop the extraintestinal spread of antibiotic-resistant bacteria via the measurement of the intestinal dominance of these organisms, thereby allowing for the application of preventive measures.
format Online
Article
Text
id pubmed-9769714
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-97697142022-12-22 Intestinal Dominance by Multidrug-Resistant Bacteria in Pediatric Liver Transplant Patients Dahdouh, Elias Fernández-Tomé, Lorena Cendejas-Bueno, Emilio Ruiz-Carrascoso, Guillermo Schüffelmann, Cristina Alós-Díez, María Lázaro-Perona, Fernando Castro-Martínez, Mercedes Escosa-García, Luis Jiménez-Rodríguez, Sonia Hierro-Llanillo, Loreto Mingorance, Jesús Microbiol Spectr Research Article Pediatric liver transplantation (PLTx) is commonly associated with extensive antibiotic treatments that can produce gut microbiome alterations and open the way to dominance by multidrug-resistant organisms (MDROs). In this study, the relationship between intestinal Relative Loads (RLs) of β-lactamase genes, antibiotic consumption, microbiome disruption, and the extraintestinal dissemination of MDROs among PLTx patients is investigated. 28 PLTx patients were included, from whom 169 rectal swabs were collected. Total DNA was extracted and bla(CTX-M-1-Family), bla(OXA-1), bla(OXA-48), and bla(VIM) were quantified via quantitative polymerase chain reaction (qPCR) and normalized to the total bacterial load (16SrRNA) through LogΔΔCt to determine the RLs. 16SrRNA sequencing was performed for 18 samples, and metagenomic sequencing was performed for 2. Patients’ clinical data were retrieved from the hospital’s database. At least one of the genes tested were detected in all of the patients. The RLs for bla(CTX-M-1-Family), bla(OXA-1), bla(OXA-48), and bla(VIM) were higher than 1% of the total bacterial population in 67 (80.73%), 56 (78.87%), 57 (77.03%) and 39 (61.9%) samples, respectively. High RLs for bla(CTX-M-1-Family), bla(OXA-1), and/or bla(OXA-48), were positively associated with the consumption of carbapenems with trimethoprim-sulfamethoxazole and coincided with low diversity in the gut microbiome. Low RLs were associated with the consumption of noncarbapenem β-lactams with aminoglycosides (P < 0.05). Extraintestinal isolates harboring the same gene(s) as those detected intraintestinally were found in 18 samples, and the RLs of the respective swabs were high. We demonstrated a relationship between the consumption of carbapenems with trimethoprim-sulfamethoxazole, intestinal dominance by MDROs and extraintestinal spread of these organisms among PLTx patients. IMPORTANCE In this study, we track the relative intestinal loads of antibiotic resistance genes among pediatric liver transplant patients and determine the relationship between this load, antibiotic consumption, and infections caused by antibiotic-resistant organisms. We demonstrate that the consumption of broad spectrum antibiotics increase this load and decrease the gut microbial diversity among these patients. Moreover, the high loads of resistance genes were related to the extraintestinal spread of multidrug-resistant organisms. Together, our data show that the tracking of the relative intestinal loads of antibiotic resistance genes can be used as a biomarker that has the potential to stop the extraintestinal spread of antibiotic-resistant bacteria via the measurement of the intestinal dominance of these organisms, thereby allowing for the application of preventive measures. American Society for Microbiology 2022-11-08 /pmc/articles/PMC9769714/ /pubmed/36346231 http://dx.doi.org/10.1128/spectrum.02842-22 Text en Copyright © 2022 Dahdouh et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Dahdouh, Elias
Fernández-Tomé, Lorena
Cendejas-Bueno, Emilio
Ruiz-Carrascoso, Guillermo
Schüffelmann, Cristina
Alós-Díez, María
Lázaro-Perona, Fernando
Castro-Martínez, Mercedes
Escosa-García, Luis
Jiménez-Rodríguez, Sonia
Hierro-Llanillo, Loreto
Mingorance, Jesús
Intestinal Dominance by Multidrug-Resistant Bacteria in Pediatric Liver Transplant Patients
title Intestinal Dominance by Multidrug-Resistant Bacteria in Pediatric Liver Transplant Patients
title_full Intestinal Dominance by Multidrug-Resistant Bacteria in Pediatric Liver Transplant Patients
title_fullStr Intestinal Dominance by Multidrug-Resistant Bacteria in Pediatric Liver Transplant Patients
title_full_unstemmed Intestinal Dominance by Multidrug-Resistant Bacteria in Pediatric Liver Transplant Patients
title_short Intestinal Dominance by Multidrug-Resistant Bacteria in Pediatric Liver Transplant Patients
title_sort intestinal dominance by multidrug-resistant bacteria in pediatric liver transplant patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769714/
https://www.ncbi.nlm.nih.gov/pubmed/36346231
http://dx.doi.org/10.1128/spectrum.02842-22
work_keys_str_mv AT dahdouhelias intestinaldominancebymultidrugresistantbacteriainpediatriclivertransplantpatients
AT fernandeztomelorena intestinaldominancebymultidrugresistantbacteriainpediatriclivertransplantpatients
AT cendejasbuenoemilio intestinaldominancebymultidrugresistantbacteriainpediatriclivertransplantpatients
AT ruizcarrascosoguillermo intestinaldominancebymultidrugresistantbacteriainpediatriclivertransplantpatients
AT schuffelmanncristina intestinaldominancebymultidrugresistantbacteriainpediatriclivertransplantpatients
AT alosdiezmaria intestinaldominancebymultidrugresistantbacteriainpediatriclivertransplantpatients
AT lazaroperonafernando intestinaldominancebymultidrugresistantbacteriainpediatriclivertransplantpatients
AT castromartinezmercedes intestinaldominancebymultidrugresistantbacteriainpediatriclivertransplantpatients
AT escosagarcialuis intestinaldominancebymultidrugresistantbacteriainpediatriclivertransplantpatients
AT jimenezrodriguezsonia intestinaldominancebymultidrugresistantbacteriainpediatriclivertransplantpatients
AT hierrollanilloloreto intestinaldominancebymultidrugresistantbacteriainpediatriclivertransplantpatients
AT mingorancejesus intestinaldominancebymultidrugresistantbacteriainpediatriclivertransplantpatients